Recruiting

Biospecimen Collection

Sponsor:

BioMarin Pharmaceutical

Code:

NCT02365376

Conditions

Rare Genetic Disorders

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.

Conditions

Rare Genetic Disorders

Study ID

NCT02365376

Start date

Jun, 2013

Status verified date

Feb, 2015

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Willing and able to provide written, signed informed consent
  • Willing and able to comply with all study procedures

Exclusion Criteria:

  • Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study
  • Concurrent disease or condition that would interfere with study participation or safety.

Study Design

Interventions and Outcome Measures

Primary outcome measure

  • continuous collection of donated study subject samples [ Time Frame: unknown, continuous sample collection ]

Central Contacts and Locations

Central contacts

Evelyn Wang

415-506-6818EWang@bmrn.com

Locations

Lurie Children's Hospital of Chicago

Recruiting

Chicago, Illinois, United States

More Information

Sponsor

BioMarin Pharmaceutical

Last update posted

Feb 18, 2015

Last verified

Feb, 2015

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by BioMarin Pharmaceutical on 2015-02-18.